Role of duct excision surgery in the treatment of pathological nipple discharge and detection of breast carcinoma: systematic review.
Journal
BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685
Informations de publication
Date de publication:
10 07 2023
10 07 2023
Historique:
received:
17
11
2022
revised:
16
03
2023
accepted:
16
05
2023
medline:
19
7
2023
pubmed:
17
7
2023
entrez:
17
7
2023
Statut:
ppublish
Résumé
The role of duct excision surgery is not clearly defined in patients with pathological nipple discharge without other clinical and radiological abnormalities. The primary aim of this systematic review was to determine the malignancy rate in patients with pathological nipple discharge after duct excision surgery (microdochectomy/major duct excision). The secondary aims were to determine the recurrence rate of pathological nipple discharge after surgery and to assess breast cancer development after surgery. MEDLINE and Embase were searched from inception to March 2023, using search terms related to 'nipple discharge', 'nipple fluid', 'microdochectomy', 'duct excision', and 'minimally invasive surgical procedure'. Studies reporting data about women who underwent duct excision surgery for pathological nipple discharge without clinical and radiological suspicion of breast cancer, as well as reporting data on women diagnosed with breast cancer after duct excision surgery, were included. A total of 318 titles were identified, of which nine publications were included in the analysis. This resulted in 1108 patients with pathological nipple discharge who underwent a duct excision. The weighted mean rate of malignancy after duct excision surgery was 8.1 per cent (ranging from 2.3 to 13.5 per cent). Three studies described the recurrence rate of pathological nipple discharge (ranging from 0 to 12 per cent) and two studies reported breast cancer development in the follow-up in a total of three patients (less than 1 per cent). The malignancy rate after duct excision surgery for pathological nipple discharge was low in patients with pathological nipple discharge without radiological and clinical abnormalities and approximately 9 of 10 patients undergo surgery for a benign cause. Improvement of the diagnostic and therapeutic workup is needed to prevent patients from undergoing (unnecessary) exploratory surgery.
Sections du résumé
BACKGROUND
The role of duct excision surgery is not clearly defined in patients with pathological nipple discharge without other clinical and radiological abnormalities. The primary aim of this systematic review was to determine the malignancy rate in patients with pathological nipple discharge after duct excision surgery (microdochectomy/major duct excision). The secondary aims were to determine the recurrence rate of pathological nipple discharge after surgery and to assess breast cancer development after surgery.
METHODS
MEDLINE and Embase were searched from inception to March 2023, using search terms related to 'nipple discharge', 'nipple fluid', 'microdochectomy', 'duct excision', and 'minimally invasive surgical procedure'. Studies reporting data about women who underwent duct excision surgery for pathological nipple discharge without clinical and radiological suspicion of breast cancer, as well as reporting data on women diagnosed with breast cancer after duct excision surgery, were included.
RESULTS
A total of 318 titles were identified, of which nine publications were included in the analysis. This resulted in 1108 patients with pathological nipple discharge who underwent a duct excision. The weighted mean rate of malignancy after duct excision surgery was 8.1 per cent (ranging from 2.3 to 13.5 per cent). Three studies described the recurrence rate of pathological nipple discharge (ranging from 0 to 12 per cent) and two studies reported breast cancer development in the follow-up in a total of three patients (less than 1 per cent).
CONCLUSION
The malignancy rate after duct excision surgery for pathological nipple discharge was low in patients with pathological nipple discharge without radiological and clinical abnormalities and approximately 9 of 10 patients undergo surgery for a benign cause. Improvement of the diagnostic and therapeutic workup is needed to prevent patients from undergoing (unnecessary) exploratory surgery.
Identifiants
pubmed: 37459137
pii: 7225205
doi: 10.1093/bjsopen/zrad066
pmc: PMC10351572
pii:
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.
Références
Ann Surg Oncol. 2005 Jul;12(7):546-51
pubmed: 15889216
Breast Cancer Res Treat. 2010 Oct;123(3):895-900
pubmed: 20354781
Breast Cancer. 2014 Mar;21(2):154-61
pubmed: 22669683
AJR Am J Roentgenol. 2015 Jul;205(1):203-8
pubmed: 26102400
BMC Cancer. 2009 May 17;9:151
pubmed: 19445720
J Am Coll Radiol. 2017 May;14(5S):S138-S153
pubmed: 28473070
Surgery. 2015 Oct;158(4):988-94; discussion 994-5
pubmed: 26243343
Breast J. 2016 Mar-Apr;22(2):202-8
pubmed: 26799061
Am J Surg. 2007 Dec;194(6):850-4; discussion 854-5
pubmed: 18005783
Cancer Treat Rev. 2001 Oct;27(5):275-82
pubmed: 11871863
J Am Coll Radiol. 2017 May;14(5S):S203-S224
pubmed: 28473077
Anticancer Res. 2020 Apr;40(4):2185-2190
pubmed: 32234913
South Med J. 1988 Jan;81(1):20-6
pubmed: 3336795
Int J Breast Cancer. 2011;2011:495315
pubmed: 22295227
Obstet Gynecol Clin North Am. 2013 Sep;40(3):459-73
pubmed: 24021252
Can J Surg. 2009 Dec;52(6):E245-8
pubmed: 20011159
Breast Cancer. 2020 Jul;27(4):607-612
pubmed: 32008216
Br J Surg. 2018 Nov;105(12):1583-1590
pubmed: 30238438
J Am Coll Surg. 2010 Mar;210(3):314-8
pubmed: 20193894
Am J Surg. 2010 Jul;200(1):73-80
pubmed: 20079481
J Clin Epidemiol. 2018 Aug;100:103-110
pubmed: 29339215
Radiol Bras. 2017 Nov-Dec;50(6):383-388
pubmed: 29307929
Breast Cancer Res Treat. 2019 Apr;174(3):703-709
pubmed: 30607630
Clin Breast Cancer. 2020 Dec;20(6):e723-e748
pubmed: 32665191
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
J Am Coll Surg. 1994 May;178(5):471-4
pubmed: 8167884
Ann R Coll Surg Engl. 2007 Mar;89(2):124-6
pubmed: 17346403
Anticancer Res. 2017 Aug;37(8):4655-4658
pubmed: 28739767
Br J Surg. 2015 Dec;102(13):1639-48
pubmed: 26447629
Ir J Med Sci. 2020 May;189(2):451-460
pubmed: 31631245
Am Surg. 2000 Oct;66(10):960-5; discussion 965-6
pubmed: 11261625
Breast J. 2018 Jul;24(4):624-627
pubmed: 29520933
World J Surg. 2015 Jan;39(1):184-6
pubmed: 25123174
BMC Cancer. 2006 Jun 23;6:164
pubmed: 16796740
Langenbecks Arch Surg. 2005 Feb;390(1):52-8
pubmed: 15372239
Ann Surg Oncol. 2003 Mar;10(2):113-6
pubmed: 12620904
Clin Breast Cancer. 2020 Jun;20(3):e334-e343
pubmed: 32081573
Ann Surg Oncol. 2013 Oct;20(10):3352-4
pubmed: 23975311
Breast J. 2016 Mar-Apr;22(2):209-12
pubmed: 26684050